Zenas BioPharma, Inc. (ZBIO)

17.91 -0.51 (-2.77%) USD  |  NASDAQ  |  Jun 10, 16:00
17.90 -0.01 (-0.06%) After-Hours: 20:00
More

Zenas BioPharma EPS Diluted (TTM) : -9.096 for March 31, 2026

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ZBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
March 31, 2026 -9.096
December 31, 2025 -8.444
September 30, 2025 -4.531
June 30, 2025 -4.233
March 31, 2025 -3.977
December 31, 2024 -3.899
September 30, 2024 -3.282
Date Value
June 30, 2024 -1.506
March 31, 2024 -1.273
December 31, 2023 -1.046
September 30, 2023 -0.4043
June 30, 2023 -1.256
March 31, 2023 -0.4984

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. 0.6779
Gilead Sciences, Inc. 7.349
Nkarta, Inc. -1.349
ACADIA Pharmaceuticals, Inc. 2.196
Alnylam Pharmaceuticals, Inc. 4.209